Celastrol

From Wikipedia, the free encyclopedia

Template:Cs1 config Page Template:Chembox/styles.css has no content.

Template:Chembox IndexlistTemplate:Chembox CompToxTemplate:Chembox Datapage check
Celastrol
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Names
IUPAC name
3-Hydroxy-9β,13α-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid
Systematic IUPAC name
(2R,4aS,6aS,12bR,14aS,14bR)-10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid
Other names
Tripterine
Identifiers
Page Template:Plainlist/styles.css has no content.
3D model (JSmol)
Page Template:Plainlist/styles.css has no content.
ChemSpider Page Template:Plainlist/styles.css has no content.
EC Number Page Template:Plainlist/styles.css has no content.
Page Template:Plainlist/styles.css has no content.
RTECS number Page Template:Plainlist/styles.css has no content.
UNII Page Template:Plainlist/styles.css has no content.
  • InChI=1S/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26-,27+,28-,29+/m1/s1
    Key: KQJSQWZMSAGSHN-JJWQIEBTSA-N
  • InChI=1/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26-,27+,28-,29+/m1/s1
    Key: KQJSQWZMSAGSHN-JJWQIEBTBS
  • CC1=C(C(=O)C=C2C1=CC=C3[C@]2(CC[C@@]4([C@@]3(CC[C@@]5([C@H]4C[C@](CC5)(C)C(=O)O)C)C)C)C)O
Properties
C29H38O4
Molar mass 450.619 g·mol−1
Appearance Crystalline solid
Melting point 213 °C (415 °F; 486 K)[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Template:Chembox Footer/trackingTemplate:Short description

Celastrol (tripterine) is a bioactive chemical compound isolated from the roots of Tripterygium wilfordii (Thunder duke vine) and Tripterygium regelii (Regel's threewingnut). Celastrol is a pentacyclic Template:Chem name and belongs to the family of quinone methides.[2] It has been used for centuries as a traditional Chinese medicine. In recent years, celastrol has been widely studied for its anti-inflammatory, anticancer, antioxidant, and antibacterial properties.[3][4][5][6]

In mice, celastrol is an NR4A1 agonist that alleviates inflammation and induces autophagy.[7] It also influences metabolic regulation by enhancing IL1R1 expression, which is the receptor for the cytokine interleukin-1 (IL-1). IL1R1 knock-out mice exposed to celastrol exhibit no leptin-sensitizing or anti-obesity effect.[8]

In in vitro and in vivo animal experiments, celastrol exhibits antibacterial,[9][6] antioxidant,[10] anti-inflammatory,[11][12] anticancer,[13][14][15][16][17] and insecticidal properties.[18] It has been shown to have obesity-controlling effects in mice by inhibiting negative regulators of leptin.[19][20][21] Celastrol has also shown to possess anti-diabetic effects on diabetic nephropathy and improve whole-body insulin resistance, through the inhibition of NF-κB signaling in the hypothalamus.[22]

Celastrol inhibits the IKK-NF-κB signaling pathway via multiple molecular mechanisms, including the direct inhibition of IKKα and IKKβ kinases, inactivation of CDC37 and p23 (HSP90 chaperone proteins), suppression of proteasome function and activation of HSF1, which triggers the heat shock response. The available evidence indicates that celastrol covalently binds to the thiol groups of cysteine residues within its molecular targets.[23]

Celastrol also has demonstrated in vitro inhibitory effects against the carbapenemase of carbapenem-resistant Klebsiella pneumoniae (CRE), particularly when used in combination with thymol, a monoterpene.[24]

Antibacterial activity against MRSA

Recent studies have identified celastrol as a potential antibacterial agent against methicillin-resistant Staphylococcus aureus (MRSA). Multi-omics analysis suggests that celastrol targets bacterial Δ¹-pyrroline-5-carboxylate dehydrogenase (P5CDH), which is an enzyme involved in proline metabolism. Molecular docking identified Lys205 and Glu208 as critical binding sites for celastrol on P5CDH.[6]

By binding to P5CDH, celastrol disrupts its function and leads to an accumulation of Δ1-pyrroline-5-carboxylate (P5C). This disruption interferes with bacterial oxidative stress regulation, resulting in an increase in reactive oxygen species (ROS) and oxidative damage. Additionally, the inhibition of P5CDH disrupts bacterial energy production and DNA synthesis, ultimately leading to bacterial cell death. Because celastrol affects multiple bacterial metabolic pathways, it is a promising candidate for drug development.[6]

Experiments in vitro demonstrated that celastrol exhibits significant antibacterial activity against Gram-positive bacteria, including multiple MRSA strains. However, it is significantly less effective against Gram-negative bacteria due to structural differences in their cell wall structures. The compound also demonstrated low levels of resistance development compared to traditional antibiotics such as vancomycin and oxacillin.[6]

In vivo studies using Galleria mellonella larvae and murine infection models showed that celastrol effectively reduced bacterial burden and improved survival rates in MRSA-infected animals. However, high doses of celastrol led to toxicity, including hepatotoxicity and renal damage. Additionally, celastrol's therapeutic window is narrow, meaning that only a specific dosage range is effective. It was also shown that in high concentrations, celastrol induces apoptosis in spleen cells. These findings suggest that celastrol may not be suitable for direct clinical use. On the other hand, celastrol should be used as a lead compound for developing safer and more effective derivatives.[6]

References

Page Template:Reflist/styles.css has no content.

  1. ^ Page Module:Citation/CS1/styles.css has no content.Ryu YB, Park SJ, Kim YM, Lee JY, Seo WD, Chang JS, et al. (March 2010). "SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii". Bioorganic & Medicinal Chemistry Letters. 20 (6): 1873–6. doi:10.1016/j.bmcl.2010.01.152. PMC 7127101. PMID 20167482.
  2. ^ Page Module:Citation/CS1/styles.css has no content.Tan JL, Yi J, Cao XY, Wang FY, Xie SL, Zhou LL, et al. (February 2023). "Celastrol: The new dawn in the treatment of vascular remodeling diseases". Biomedicine & Pharmacotherapy. 158 114177. doi:10.1016/j.biopha.2022.114177. PMID 36809293.
  3. ^ Page Module:Citation/CS1/styles.css has no content.Lei H, Ruan Y, Ding R, Li H, Zhang X, Ji X, et al. (January 2025). "The role of celastrol in inflammation and diseases". Inflammation Research. 74 (1) 23. doi:10.1007/s00011-024-01983-5. PMID 39862265.
  4. ^ Page Module:Citation/CS1/styles.css has no content.Kashyap D, Sharma A, Tuli HS, Sak K, Mukherjee T, Bishayee A (August 2018). "Molecular targets of celastrol in cancer: Recent trends and advancements". Critical Reviews in Oncology/Hematology. 128: 70–81. doi:10.1016/j.critrevonc.2018.05.019. PMID 29958633.
  5. ^ Page Module:Citation/CS1/styles.css has no content.Xu H, Zhao H, Ding C, Jiang D, Zhao Z, Li Y, et al. (February 2023). "Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1". Signal Transduction and Targeted Therapy. 8 (1) 51. doi:10.1038/s41392-022-01231-4. PMC 9895061. PMID 36732502.
  6. ^ a b c d e f Page Module:Citation/CS1/styles.css has no content.Yuan Z, Wang J, Qu Q, Zhu Z, Xu M, Zhao M, et al. (September 2023). "Celastrol Combats Methicillin-Resistant Staphylococcus aureus by Targeting Δ1 -Pyrroline-5-Carboxylate Dehydrogenase". Advanced Science. 10 (25) e2302459. doi:10.1002/advs.202302459. PMC 10477891. PMID 37381655.
  7. ^ Page Module:Citation/CS1/styles.css has no content.Zhang L, Wang Q, Liu W, Liu F, Ji A, Li Y (2018). "The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases". Journal of Diabetes Research. 2018 9363461. doi:10.1155/2018/9363461. PMC 6022324. PMID 30013988.
  8. ^ Page Module:Citation/CS1/styles.css has no content.Feng X, Guan D, Auen T, Choi JW, Salazar Hernández MA, Lee J, et al. (April 2019). "IL1R1 is required for celastrol's leptin-sensitization and antiobesity effects". Nature Medicine. 25 (4): 575–582. doi:10.1038/s41591-019-0358-x. PMC 7158951. PMID 30833749.
  9. ^ Page Module:Citation/CS1/styles.css has no content.Padilla-Montaño N, de León Guerra L, Moujir L (March 2021). "Antimicrobial Activity and Mode of Action of Celastrol, a Nortriterpen Quinone Isolated from Natural Sources". Foods. 10 (3): 591. doi:10.3390/foods10030591. PMC 7998816. PMID 33799720.
  10. ^ Page Module:Citation/CS1/styles.css has no content.Allison AC, Cacabelos R, Lombardi VR, Alvarez XA, Vigo C (October 2001). "Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25 (7): 1341–57. doi:10.1016/S0278-5846(01)00192-0. PMID 11513350. S2CID 21569585.
  11. ^ Page Module:Citation/CS1/styles.css has no content.Kim DH, Shin EK, Kim YH, Lee BW, Jun JG, Park JH, et al. (September 2009). "Suppression of inflammatory responses by celastrol, a quinone methide triterpenoid isolated from Celastrus regelii". European Journal of Clinical Investigation. 39 (9): 819–27. doi:10.1111/j.1365-2362.2009.02186.x. PMID 19549173. S2CID 205291261.
  12. ^ Page Module:Citation/CS1/styles.css has no content.Venkatesha SH, Yu H, Rajaiah R, Tong L, Moudgil KD (April 2011). "Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses". The Journal of Biological Chemistry. 286 (17): 15138–46. doi:10.1074/jbc.M111.226365. PMC 3083183. PMID 21402700.
  13. ^ Page Module:Citation/CS1/styles.css has no content.Metselaar DS, Meel MH, Benedict B, Waranecki P, Koster J, Kaspers GJ, et al. (November 2019). "Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin". eBioMedicine. 50: 81–92. doi:10.1016/j.ebiom.2019.10.062. PMC 6921187. PMID 31735550.
  14. ^ Page Module:Citation/CS1/styles.css has no content.Lee JH, Choi KJ, Seo WD, Jang SY, Kim M, Lee BW, et al. (March 2011). "Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90". International Journal of Molecular Medicine. 27 (3): 441–6. doi:10.3892/ijmm.2011.601. PMID 21249311.
  15. ^ Page Module:Citation/CS1/styles.css has no content.Tiedemann RE, Schmidt J, Keats JJ, Shi CX, Zhu YX, Palmer SE, et al. (April 2009). "Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo". Blood. 113 (17): 4027–37. doi:10.1182/blood-2008-09-179796. PMC 3952546. PMID 19096011.
  16. ^ Page Module:Citation/CS1/styles.css has no content.Zhu H, Liu XW, Cai TY, Cao J, Tu CX, Lu W, et al. (August 2010). "Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway". The Journal of Pharmacology and Experimental Therapeutics. 334 (2): 489–99. doi:10.1124/jpet.110.165654. PMID 20472666. S2CID 25854329.
  17. ^ Page Module:Citation/CS1/styles.css has no content.Byun JY, Kim MJ, Eum DY, Yoon CH, Seo WD, Park KH, et al. (October 2009). "Reactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cells". Molecular Pharmacology. 76 (4): 734–44. doi:10.1124/mol.109.056259. PMID 19574249. S2CID 6541041.
  18. ^ Page Module:Citation/CS1/styles.css has no content.Avilla J, Teixidò A, Velázquez C, Alvarenga N, Ferro E, Canela R (January 2000). "Insecticidal activity of Maytenus species (Celastraceae) nortriterpene quinone methides against codling moth, Cydia pomonella (L.) (Lepidoptera: tortricidae)". Journal of Agricultural and Food Chemistry. 48 (1): 88–92. Bibcode:2000JAFC...48...88A. doi:10.1021/jf990008w. PMID 10637057.
  19. ^ Kyriakou E, Schmidt S, Dodd GT, et al. Celastrol Promotes Weight Loss in Diet-Induced Obesity by Inhibiting the Protein Tyrosine Phosphatases PTP1B and TCPTP in the Hypothalamus. J Med Chem. 2018;61(24):11144-11157. doi:10.1021/acs.jmedchem.8b01224
  20. ^ Page Module:Citation/CS1/styles.css has no content.Pfuhlmann K, Schriever SC, Baumann P, Kabra DG, Harrison L, Mazibuko-Mbeje SE, et al. (November 2018). "Celastrol-Induced Weight Loss Is Driven by Hypophagia and Independent From UCP1". Diabetes. 67 (11): 2456–2465. doi:10.2337/db18-0146. PMID 30158241.
  21. ^ Page Module:Citation/CS1/styles.css has no content.Liu J, Lee J, Salazar Hernandez MA, Mazitschek R, Ozcan U (May 2015). "Treatment of obesity with celastrol". Cell. 161 (5): 999–1011. Bibcode:2015Cell..161..999L. doi:10.1016/j.cell.2015.05.011. PMC 4768733. PMID 26000480.
  22. ^ Page Module:Citation/CS1/styles.css has no content.Kim JE, Lee MH, Nam DH, Song HK, Kang YS, Lee JE, et al. (2013). "Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice". PLOS ONE. 8 (4) e62068. Bibcode:2013PLoSO...862068K. doi:10.1371/journal.pone.0062068. PMC 3637455. PMID 23637966.File:Creative Commons by small.svg This article incorporates text from this source, which is available under the CC BY 4.0 license.
  23. ^ Page Module:Citation/CS1/styles.css has no content.Salminen A, Lehtonen M, Paimela T, Kaarniranta K (April 2010). "Celastrol: Molecular targets of Thunder God Vine". Biochem Biophys Res Commun. 394 (3): 439–42. Bibcode:2010BBRC..394..439S. doi:10.1016/j.bbrc.2010.03.050. PMID 20226165.
  24. ^ Page Module:Citation/CS1/styles.css has no content.Abdel-Halim MS, Askoura M, Mansour B, Yahya G, El-Ganiny AM (27 September 2022). "In vitro activity of celastrol in combination with thymol against carbapenem-resistant Klebsiella pneumoniae isolates". The Journal of Antibiotics. 75 (12): 679–690. doi:10.1038/s41429-022-00566-y. PMC 9640353. PMID 36167781.